This webinar will review the current evidence on the safety and efficacy of ketamine therapy for patients with treatment resistant major depressive disorder. The National LGBTQIA+ Health Education Center will present different methods for delivering ketamine and referring patients to treatment and will discuss other emerging depression treatments. The presentation will discuss these treatments through the lens of providing high-quality, culturally responsive care for LGTBQIA+ patients. The webinar will take place on February 11, 2025.
Register today with the National LGBTQIA+ Health Education Center!
Leave a Reply
You must be logged in to post a comment.